Bone morphogenetic protein-2 plasmid DNA as a substitute for bone morphogenetic protein-2 protein in bone tissue engineering

Tissue Engineering - Part A

Volumn 19, Issue 23-24, 2013, Pages 2686-2692

  Wegman, Fiona ^a   Van Der Helm, Yvonne ^a   Öner, F Cumhur ^a   Dhert, Wouter J A ^a,b   Alblas, Jacqueline ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; GENE TRANSFER; PROTEINS; TISSUE ENGINEERING;

BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; BONE TISSUE ENGINEERING; CLINICAL APPLICATION; ECTOPIC BONE FORMATIONS; GENE DELIVERY; REGENERATIVE MEDICINE;

BONE;

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; PLASMID DNA; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; OSSIFICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALGINATES; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GLUCURONIC ACID; GOATS; HEXURONIC ACIDS; HUMANS; MICE; PLASMIDS; TISSUE ENGINEERING;

EID: 84889871172     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0569     Document Type: Article

References (36)

1. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
2. Riley, E.H., Lane, J.M., Urist, M.R., Lyons, K.M., and Lieberman, J.R. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res 324, 39, 1996.
3. Boden, S.D., Kang, J., Sandhu, H., and Heller, J.G. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27, 2662, 2002.
4. Poynton, A.R., and Lane, J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 27, 40, 2002.
5. Carragee, E.J., Hurwitz, E.L., and Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11, 471, 2011.
6. Shimer, A.L., Oner, F.C., and Vaccaro, A.R. Spinal reconstruction and bone morphogenetic proteins: open questions. Injury 40, 32, 2009.
7. Glassman, S.D., Gum, J.L., Crawford, C.H., 3rd., Shields, C.B., and Carreon, L.Y. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear. Spine J 11, 522, 2011.
8. Southwood, L.L., Frisbie, D.D., Kawcak, C.E., and McIlwraith, C.W. Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg 33, 565, 2004.
9. Pietersz, G.A., Tang, C.K., and Apostolopoulos, V. Structure and design of polycationic carriers for gene delivery. Mini Rev Med Chem 6, 1285, 2006.
10. Luo, D., and Saltzman, W.M. Synthetic DNA delivery systems. Nat Biotechnol 18, 33, 2000.
11. Louise, C. Nonviral vectors. Methods Mol Biol 333, 201, 2006.
12. Pelled, G., Ben-Arav, A., Hock, C., Reynolds, D.G., Yazici, C., Zilberman, Y., et al. Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng Part B Rev 16, 13, 2010.
13. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5, 753, 1999.
14. Wegman, F., Bijenhof, A., Schuijff, L., Oner, F.C., Dhert, W.J., and Alblas, J. Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur Cell Mater 21, 230, 2011.
15. Kong, H.J., Kim, E.S., Huang, Y.C., and Mooney, D.J. Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 25, 1230, 2008.
16. Park, D.J., Choi, J.H., Leong, K.W., Kwon, J.W., and Eun, H.S. Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique. Laryngoscope 117, 1267, 2007.
17. Jain, S., and Amiji, M. Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromolecules 13, 1074, 2012.
18. Krebs, M.D., Sutter, K.A., Lin, A.S., Guldberg, R.E., and Alsberg, E. Injectable poly(lactic-co-glycolic) acid scaffolds with in situ pore formation for tissue engineering. Acta Biomater 5, 2847, 2009.
19. Saraf, A., Hacker, M.C., Sitharaman, B., Grande-Allen, K.J., Barry, M.A., and Mikos, A.G. Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 9, 818, 2008.
20. Gwak, S.J., and Kim, B.S. Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine. Biotechnol Lett 30, 1177, 2008.
21. Moreira, C., Oliveira, H., Pires, L.R., Simõ es, S., Barbosa, M.A., and Pêgo, A.P. Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. Acta Biomater 5, 2995, 2009.
22. Wegman, F., Ö ner, F.C., Dhert, W.J., and Alblas, J. Non-viral gene therapy for bone tissue engineering. Biotechnol Genet Eng Rev 29, 206, 2013.
23. Stevens, M.M., Marini, R.P., Schaefer, D., Aronson, J., Langer, R., and Shastri, V.P. In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci USA 102, 11450, 2005.
24. Hunt, N.C., and Grover, L.M. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32, 733, 2010.
25. van Gaalen, S.M., Kruyt, M.C., Geuze, R.E., de Bruijn, J.D., Alblas, J., and Dhert, W.J. Use of fluorochrome labels in in vivo bone tissue engineering research. Tissue Eng Part B Rev 16, 209, 2010.
26. Lam, A.P., and Dean, D.A. Progress and prospects: nuclear import of nonviral vectors. Gene Ther 17, 439, 2010.
27. Olabisi, R.M., Lazard, Z., Heggeness, M.H., Moran, K.M., Hipp, J.A., Dewan, A.K., et al. An injectable method for noninvasive spine fusion. Spine J 11, 545, 2011.
28. Geuze, R.E., Prins, H.J., Oner, F.C., van der Helm, Y.J., Schuijff, L.S., Martens, A.C., Kruyt, M.C., Alblas, J., and Dhert, W.J. Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng Part A 16, 3343, 2010.
29. LeGeros, R.Z., Lin, S., Rohanizadeh, R., Mijares, D., and LeGeros, J.P. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 14, 201, 2003.
30. Geuze, R.E., Everts, P.A., Kruyt, M.C., Verbout, A.J., Alblas, J., and Dhert, W.J. Orthotopic location has limited benefit from allogeneic or autologous multipotent stromal cells seeded on ceramic scaffolds. Tissue Eng Part A 15, 3231, 2009.
31. Angle, S.R., Sena, K., Sumner, D.R., Virkus, W.W., and Virdi, A.S. Healing of rat femoral segmental defect with bone morphogenetic protein-2: a dose response study. J Musculoskelet Neuronal Interact 12, 28, 2012.
32. Lee, J.H., Yu, C.H., Yang, J.J., Baek, H.R., Lee, K.M., Koo, T.Y., et al. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 12, 239, 2012.
33. Kolambkar, Y.M., Boerckel, J.D., Dupont, K.M., Bajin, M., Huebsch, N., Mooney, D.J., et al. Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone 49, 485, 2011.
34. Aslan, H., Sheyn, D., and Gazit, D. Genetically engineered mesenchymal stem cells: applications in spine therapy. Regen Med 4, 99, 2009.
35. Schindeler, A., McDonald, M.M., Bokko, P., and Little, D.G. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19, 459, 2008.
36. Mackie, E.J., Ahmed, Y.A., Tatarczuch, L., Chen, K.S., and Mirams, M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40, 46, 2008.